Auro Laboratories Ltd.
| BSE: 530233 | Sector: Health care |
| NSE: N.A. | ISIN Code: INE292C01011 |
| BSE 16:00 | 23 Apr | 99.80 |
-6.05 (-5.72%) |
OPEN
110.95 |
HIGH
114.75 |
LOW
96.00 |
| NSE 05:30 | 01 Jan | Auro Laboratories Ltd |
| OPEN | 110.95 |
| PREVIOUS CLOSE | 105.85 |
| VOLUME | 142013 |
| 52-Week high | 128.40 |
| 52-Week low | 35.15 |
| P/E | 10.13 |
| Mkt Cap.(Rs cr) | 62 |
| Buy Price | 0.00 |
| Buy Qty | 0.00 |
| Sell Price | 0.00 |
| Sell Qty | 0.00 |
Auro Laboratories Ltd. (AUROLABS) - Net Profit
Net Profit
| COMPANY | LATEST(Rs) | CHG | CHG(%) | Net Profit (Rs crore) |
| Sun Pharma.Inds. | 637.65 | -2.60 | -0.41 | 3211.14 |
| Dr Reddy's Labs | 5080.25 | -119.45 | -2.30 | 2937.70 |
| Cipla | 935.50 | -8.85 | -0.94 | 2318.17 |
| Aurobindo Pharma | 992.05 | -0.90 | -0.09 | 1872.74 |
| Cadila Health. | 571.20 | 18.95 | 3.43 | 1412.90 |
| Divi's Lab. | 3780.00 | 25.70 | 0.68 | 1372.71 |
| Glenmark Pharma. | 559.05 | -8.45 | -1.49 | 1354.55 |
| Alkem Lab | 2778.00 | -20.45 | -0.73 | 1264.42 |
| Alembic Pharma | 999.00 | -4.70 | -0.47 | 969.40 |
| Torrent Pharma. | 2533.25 | -43.50 | -1.69 | 938.51 |
| Gland Pharma | 2670.00 | 12.05 | 0.45 | 772.86 |
| Lupin | 1079.00 | 17.70 | 1.67 | 727.55 |
| Ipca Labs. | 2105.00 | 3.25 | 0.15 | 652.46 |
| Abbott India | 14975.00 | -118.55 | -0.79 | 592.93 |
| Fortis Health. | 207.65 | -3.55 | -1.68 | 513.33 |
| Pfizer | 5171.60 | -47.70 | -0.91 | 509.13 |
| Sanofi India | 7584.75 | -23.70 | -0.31 | 477.60 |
| Natco Pharma | 877.20 | 0.10 | 0.01 | 474.50 |
| Apollo Hospitals | 3190.35 | -40.20 | -1.24 | 470.30 |
| Granules India | 329.50 | -2.55 | -0.77 | 444.07 |
Quick Links for Auro Laboratories:
-
News
Announcements Brokerage Reports Business Earnings Sector -
Corporate Action
AGM Board Meetings Bonus Dividends EGM Rights Split -
INFORMATION
Bulk Deals Company History MF Holding Listing Info Locations Shareholding -
Financials
Financial Overview Balance Sheet Profit & Loss Cash Flow Ratios Quarterly Results Half Yearly Results Nine Monthly Results Yearly Results -
Annual Report
Auditors Report Chairman's Speech Company Management Directors' Report Finished Goods Raw Materials -
Peer Comparison
Competition Market Cap Price Price Performance Net Sales Net Profit Total Assets Historical Prices
